Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMA1-DiCo Vaccine in Healthy European and African Adults
NCT02014727Phase 1Completed
- Sponsor
- Inserm
- Start
- Jan 2014
- Primary completion
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of AMA1-DiCo in malaria, sponsored by Inserm. Started Jan 2014; status: completed.
02
Drugs
AMA1-DiCo
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02014727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014727.